BiotechTube
Home/ENYO Pharma/Dr Raphaël Darteil, PhD
DR

Dr Raphaël Darteil, PhD

SVP Head of non-clinical Development & Profiling

ENYO Pharma

Therapeutic Areas

NephrologyHepatologyMetabolic Diseases

ENYO Pharma Pipeline

DrugIndicationPhase
Vonafexor (EYP001)Alport SyndromePhase 2

Leadership Team at ENYO Pharma

DJ
Dr Jacky Vonderscher, PhD
Co-founder and Chief Executive Officer
DP
Dr Pietro Scalfaro, MD, MBA
SVP Head of Clinical Development, Chief Medical Officer
KM
Keltoum Medji, MBA
VP Finance and Strategic Development
View full ENYO Pharma profile